Key points from article :
16 people with mild or moderate Alzheimer’s disease received weekly injections of young plasma.
Patients did no better on cognitive tests administered by researchers.
Caregivers reported that their charges performed slightly better at daily tasks.
Startup company Alkahest is “encouraged” to run more trials.
